Sign In
Buy ALVR
$9.81
+0 (+0%)
At Close: Jun 17, 2025
U.S. IPO Week Ahead: Chinese EV's Billion-Dollar Deal Closes Out Summer In A 2-IPO Week
05:37am, Sunday, 23'rd Aug 2020
Two IPOs and two SPACs are scheduled to go public in the week ahead. Chinese EV maker Xpeng is leading summer's last wave with a billion-dollar deal.
Stocks To Watch: Spotlight On Palo Alto Networks, Best Buy And Xpeng Motors
08:12am, Saturday, 22'nd Aug 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday
CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced the closing of its upsized initial public offering of 18,6
AlloVir prices upsized IPO at $17, to be valued at over $1 billion
12:53pm, Thursday, 30'th Jul 2020
AlloVir Inc. said Thursday that its upsized initial public offering priced at $17 a share, in the middle of the expected range of $16 to $18 a share. The company sold 16.25 million shares to raise $2
AlloVir Announces Pricing of Upsized Initial Public Offering
11:32am, Thursday, 30'th Jul 2020
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced the pricing of its upsized initial public offering of 16,2
IPO Update: AlloVir Proposes Terms For $251 Million IPO
12:18pm, Sunday, 26'th Jul 2020
AlloVir intends to raise $251 million in a U.S. IPO of its common stock.
U.S. IPO Week Ahead: Tax Software Leads A Diverse 7-IPO Week
08:52am, Saturday, 25'th Jul 2020
Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex.
U.S. IPO Week Ahead: Software Provider Jamf Takes The Spotlight In A Diverse 4-IPO Week
09:13am, Saturday, 18'th Jul 2020
Four IPOs and one SPAC plan to raise $663 million in the week ahead, led by Jamf Holding. The IPO market is on a hot streak, and the IPO pipeline is filling up as filing activity remains high.
AlloVir Seeks IPO For Anti-Viral Pipeline Development
03:38pm, Thursday, 16'th Jul 2020
AlloVir has filed to raise $100 million in an IPO. The firm is advancing a pipeline of treatments and preventions for various viral diseases, including Covid19.
U.S. IPO Weekly Recap: Preclinical Biotech Nkarta Pops 166% In A 5 IPO Week
08:22am, Sunday, 12'th Jul 2020
Three biotechs, two Chinese issuers, and one SPAC went public this past week. Preclinical oncology biotech Nkarta popped 166% in the best first-day return for a $10+ million IPO since 2015.
